Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel

NCT00697437 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Docetaxel
DRUG: Ketoconazole

Sponsor

National University Hospital, Singapore